Finch feeds data from microbial interventions into our integrated machine-learning platform to identify the specific microbial agents that drive clinical responses. This human-first discovery enables us to develop these microbes as synthetic ecologies, a new generation of defined microbial therapies.
We're unlocking the therapeutic potential of the human microbiome.
A human-first discovery platform accelerates our development of microbial therapeutics.
Read more about our proprietary synthetic ecologies and Aquashell™ technology.